(Q51499942)

English

Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma

scientific article published in March 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

laryngeal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Alvarez Pérez RM

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Borrego Dorado I

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Vázquez Albertino R

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Ruiz Franco-Baux J

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Ceballo Pedraja JM

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Esteban Ortega F

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Acta Otorrinolaringológica Española

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

57

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

134-139

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Uses and limitations of FDG positron emission tomography in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Correlation of fine needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of locally recurrent and metastatic head and neck neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0001-6519%2806%2978678-2

7 January 2021

Identifiers

10.1016/S0001-6519(06)78678-2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16615566

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51499942&oldid=2275867428"